Benzinga | Nov 5, 2021 09:27AM EDT

Medifast Q3 EPS $3.56 Beats $3.08 Estimate, Sales $413.40M Beat $403.76M Estimate; Sees FY21 Sales $1.51B-$1.53B vs $1.52B Estimate, EPS $13.27-$13.96 vs $13.93 Estimate

Medifast (NYSE:MED) reported quarterly earnings of $3.56 per share which beat the analyst consensus estimate of $3.08 by 15.58 percent. This is a 22.34 percent increase over earnings of $2.91 per share from the same period last year. The company reported quarterly sales of $413.40 million which beat the analyst consensus estimate of $403.76 million by 2.39 percent. This is a 52.28 percent increase over sales of $271.47 million the same period last year.